IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+4.48%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-8.3%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-9.26%
Top 10 Holdings %
Top 10 Hldgs %
51.54%
Holding
77
New
13
Increased
17
Reduced
12
Closed
16
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.4M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$8.92M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.89M |
| 4 |
Gilead Sciences
GILD
|
$6.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$6.65M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$40.5M |
| 2 |
Alkermes
ALKS
|
$16.7M |
| 3 |
Exelixis
EXEL
|
$10.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$8.48M |
| 5 |
Sanofi
SNY
|
$7.81M |
Sector Composition
| 1 | Healthcare | 99.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Erasca
ERAS
$406M
| $3.92M | 1.19% |
1,426,000
| – | – |
|
|
27
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.69M | 1.12% |
80,052
-184,000
| -70% | -$8.48M |
|
28
Akero Therapeutics
AKRO
$3.65B
| $3.66M | 1.11% |
+78,489
| New | +$3.66M |
|
29
Acadia Pharmaceuticals
ACAD
$4.34B
| $3.62M | 1.1% |
151,000
-65,000
| -30% | -$1.56M |
|
30
Halozyme
HALO
$8.75B
| $3.44M | 1.05% |
95,500
+50,000
| +110% | +$1.8M |
|
31
Dyne Therapeutics
DYN
$1.92B
| $3.38M | 1.03% |
300,751
-133,000
| -31% | -$1.5M |
|
32
Biogen
BIIB
$20.8B
| $3.13M | 0.95% |
11,000
-10,400
| -49% | -$2.96M |
|
33
Rocket Pharmaceuticals
RCKT
$358M
| $3.09M | 0.94% |
156,000
+93,000
| +148% | +$1.84M |
|
34
Legend Biotech
LEGN
$6.64B
| $2.62M | 0.8% |
38,000
| – | – |
|
35
Zai Lab
ZLAB
$3.48B
| $2.19M | 0.67% |
78,958
| – | – |
|
36
Sarepta Therapeutics
SRPT
$1.98B
| $2.15M | 0.66% |
+18,800
| New | +$2.15M |
|
37
Jazz Pharmaceuticals
JAZZ
$7.99B
| $2.13M | 0.65% |
17,200
| – | – |
|
38
Ionis Pharmaceuticals
IONS
$9.64B
| $1.76M | 0.54% |
43,000
| – | – |
|
39
Mirum Pharmaceuticals
MIRM
$3.75B
| $1.74M | 0.53% |
67,500
| – | – |
|
40
Celldex Therapeutics
CLDX
$1.57B
| $1.63M | 0.5% |
+48,099
| New | +$1.63M |
|
|
ONC
41
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $1.55M | 0.47% |
8,700
-14,000
| -62% | -$2.49M |
|
42
NovoCure
NVCR
$1.35B
| $1.33M | 0.4% |
32,000
| – | – |
|
43
Guardant Health
GH
$8.11B
| $1.31M | 0.4% |
36,500
-38,000
| -51% | -$1.36M |
|
44
Cytokinetics
CYTK
$5.98B
| $1.21M | 0.37% |
+37,000
| New | +$1.21M |
|
45
Xenon Pharmaceuticals
XENE
$2.99B
| $982K | 0.3% |
25,500
| – | – |
|
46
Intellia Therapeutics
NTLA
$1.26B
| $978K | 0.3% |
24,000
| – | – |
|
|
MRNS
47
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $977K | 0.3% |
+90,000
| New | +$977K |
|
|
SAGE
48
DELISTED
Sage Therapeutics
SAGE
| $939K | 0.29% |
+20,000
| New | +$939K |
|
|
IMAB
49
I-MAB
IMAB
$380M
| $925K | 0.28% |
310,499
| – | – |
|
50
Insmed
INSM
$30.3B
| $845K | 0.26% |
40,100
| – | – |
|